-
Cytoskeletal dynamics and mitochondrial rearrangements drive cell fate upon antibody-induced complement activation in DLBCL
van der Horst, H. J., Csikós, T., Quik, M., van der Schans, J. J., de Lint, K., Nuñez Moreno, G., Guan, M., Karagoz, K., Breij, E. C. W., Santegoets, K. C. M., Chamuleau, M. E. D., Roukens, M. G., Overdijk, M. B. & Mutis, T., 1 Dec 2025, In: Blood Cancer Journal. 15, 1, 156.Research output: Contribution to journal › Article › Academic › peer-review
-
Enhancing Fc-mediated effector functions of monoclonal antibodies: The example of HexaBodies
van der Horst, H. J. & Mutis, T., Nov 2024, In: Immunological reviews. 328, 1, p. 456-465 10 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Moving cancer therapy forward: Engineered antibodies for the treatment of B-cell malignancies
van der Horst, H. J., 2 Nov 2021, Amsterdam: s.n.. 204 p.Research output: PhD thesis › Research HvA, graduation HvA (not in use)
- All publications
